Activin and Inhibin

ALPK1-IN-2 (compound T001) is a potent ALPK1 (alpha-kinase 1) inhibitor, with an IC 50 of 95 nM. ALPK1-IN-2 also inhibits NF-κB , with an IC 50 of 1.31 μMForm:SolidIC50&amp: Target:IC 50 : 95 nM (ALPK1), 1.31 μM (NF-κB).

ALR2-IN-1 is a potent and selective ALR2 inhibitor ( IC 50 =1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication researchForm:SolidIC50&amp: Target:IC50: 1.42 μM (ALR2) &gt:100 μM (ALR1).

ALR2-IN-1 is a potent and selective ALR2 inhibitor ( IC 50 =1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication researchForm:SolidIC50&amp: Target:IC50: 1.42 μM (ALR2) &gt:100 μM (ALR1).

ALR2-IN-1 is a potent and selective ALR2 inhibitor ( IC 50 =1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication researchForm:SolidIC50&amp: Target:IC50: 1.42 μM (ALR2) &gt:100 μM (ALR1).

ALR2-IN-1 is a potent and selective ALR2 inhibitor ( IC 50 =1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication researchForm:SolidIC50&amp: Target:IC50: 1.42 μM (ALR2) &gt:100 μM (ALR1).

ALR2-IN-1 is a potent and selective ALR2 inhibitor ( IC 50 =1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication researchForm:SolidIC50&amp: Target:IC50: 1.42 μM (ALR2) &gt:100 μM (ALR1).

Alrizomadlin (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC 50 and K i values of 3.8 nM and 1 nM, respectively Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in

Alrizomadlin (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC 50 and K i values of 3.8 nM and 1 nM, respectively Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in

Alrizomadlin (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC 50 and K i values of 3.8 nM and 1 nM, respectively Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in

ALS-8112 is a potent and selective respiratory syncytial virus ( RSV ) polymerase inhibitor. The 5'-triphosphate form of ALS-8112 inhibits RSV polymerase with an IC 50 of 0.02 μM.In VitroThe 5'-triphosphate form of ALS-8112 (ALS-8112-TP) is the

ALS-8112 is a potent and selective respiratory syncytial virus ( RSV ) polymerase inhibitor. The 5'-triphosphate form of ALS-8112 inhibits RSV polymerase with an IC 50 of 0.02 μM.In VitroThe 5'-triphosphate form of ALS-8112 (ALS-8112-TP) is the

ALS-8112 is a potent and selective respiratory syncytial virus ( RSV ) polymerase inhibitor. The 5'-triphosphate form of ALS-8112 inhibits RSV polymerase with an IC 50 of 0.02 μM.In VitroThe 5'-triphosphate form of ALS-8112 (ALS-8112-TP) is the